
Carisma Therapeutics Announces Restructuring and Pipeline Reprioritization Amid Quarterly Financial Report
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM), a pioneering firm in the field of cancer treatment, has unveiled a series of strategic changes alongside its financial results for the …
Carisma Therapeutics Announces Restructuring and Pipeline Reprioritization Amid Quarterly Financial Report Read More